Vybrique Film
Product Images NDC 71858-0205

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Vybrique (NDC 71858-0205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ibsa Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil Citrate Is Designated Chemically As 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine Citrate, Has The Molecular Formu (Vybrique Sildenafil Citrate Oral Film 01)

FDA Label Image

Figure 1 (Vybrique Sildenafil Citrate Oral Film 02)

This is a chart showing systolic blood pressure levels for young volunteers aged 18-45 years over a certain period of time after taking either Sildenafil 100 mg oral film or a placebo. The blood pressure readings are given in mmHg.*

FDA Label Image

Figure 2 (Vybrique Sildenafil Citrate Oral Film 03)

FDA Label Image

Figure 3 (Vybrique Sildenafil Citrate Oral Film 04)

FDA Label Image

Figure 4 (Vybrique Sildenafil Citrate Oral Film 05)

FDA Label Image

Figure 5 (Vybrique Sildenafil Citrate Oral Film 06)

FDA Label Image

Figure 6 (Vybrique Sildenafil Citrate Oral Film 07)

FDA Label Image

Figure 7 (Vybrique Sildenafil Citrate Oral Film 08)

FDA Label Image

Figure 8 (Vybrique Sildenafil Citrate Oral Film 09)

Percentage patients reporting improvement in a study comparing the effectiveness of Placebo, Sildenafil Citrate 50mg, and Sildenafil Citrate 100mg as treatments. The overall results show a significant difference between the treatment groups, with a p-value of less than 0.0001. The sample size varied, with N=214, N=391, and N=380 for each treatment group respectively.*

FDA Label Image

A (Vybrique Sildenafil Citrate Oral Film 0a)

FDA Label Image

B (Vybrique Sildenafil Citrate Oral Film 0b)

FDA Label Image

C (Vybrique Sildenafil Citrate Oral Film 0c)

FDA Label Image

D (Vybrique Sildenafil Citrate Oral Film 0d)

FDA Label Image

Principal Display Panelndc 71858-0205-5vybrique(sildenafil) Oral Film25 mg Per Oral Film4 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 0e)

FDA Label Image

Principal Display Panelndc 71858-0205-6vybrique(sildenafil) Oral Film25 mg Per Oral Film8 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 0f)

FDA Label Image

Principal Display Panelndc 71858-0205-4vybrique(sildenafil) Oral Film25 mg Per Oral Film1 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 10)

FDA Label Image

Principal Display Panelndc 71858-0210-5vybrique(sildenafil) Oral Film50 mg Per Oral Film4 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 11)

FDA Label Image

Principal Display Panelndc 71858-0210-6vybrique(sildenafil) Oral Film50 mg Per Oral Film8 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 12)

FDA Label Image

Principal Display Panelndc 71858-0210-4vybrique(sildenafil) Oral Film50 mg Per Oral Film1 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 13)

This text provides essential information about a medication. It includes the NDC code, dosage details, and the name of the distributing company, 185A Pharma Inc. The medication appears to contain sildenafil citrate equivalent to 50 mg of sildenafil. Dosage information is recommended to be obtained through prescribing information.*

FDA Label Image

Principal Display Panelndc 71858-0215-5vybrique(sildenafil) Oral Film75 mg Per Oral Film4 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 14)

FDA Label Image

Principal Display Panelndc 71858-0215-6vybrique(sildenafil) Oral Film75 mg Per Oral Film8 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 15)

FDA Label Image

Principal Display Panelndc 71858-0215-4vybrique(sildenafil) Oral Film75 mg Per Oral Film1 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 16)

Description: This text provides information about "Vybrique" sildenafil oral film, containing 75 mg of sildenafil citrate. It mentions to keep the film in the pouch until use and advises checking the prescribing information for the usual dosage. The product is distributed by 1BSA Pharma Inc.*

FDA Label Image

Principal Display Panelndc 71858-0220-5vybrique(sildenafil) Oral Film100 mg Per Oral Film4 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 17)

FDA Label Image

Principal Display Panelndc 71858-0220-6vybrique(sildenafil) Oral Film100 mg Per Oral Film8 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 18)

FDA Label Image

Principal Display Panelndc 71858-0220-4vybrique(sildenafil) Oral Film100 mg Per Oral Film1 Oral Filmsrx (Vybrique Sildenafil Citrate Oral Film 19)

This text appears to be a description of a medication called Vybrique, which is an oral film containing sildenafil. It is recommended to store the medication in a cool, dry place and keep it in the original pouch until ready for use. Each film contains sildenafil citrate equivalent to 100 mg of sildenafil. The text also mentions the usual dosage instructions, which should be checked in the prescribing information. The medication is distributed by IBSA Pharma Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.